RenewMe Dermatology Seminar Highlights Mirajet's Impact

RenewMe Dermatology announced that it successfully completed a seminar held exclusively for its affiliated medical staff on March 17th.

This seminar featured eight programs in the morning and a live seminar in the afternoon. The medical staff at RenewMe Dermatology had the opportunity to exchange their know-how on treating specific skin conditions and their unique golden combinations of various dermatological devices used for skin beauty treatments.

Especially noteworthy from this seminar was the enthusiastic response to Mirajet, a needle-free injection device based on laser technology developed by JSK Biomed. JSK Biomed's CEO, Jinwoo Jeon, who attended the event, communicated with the medical staff, unveiling a newly established treatment protocol based on several years of clinical research. RenewMe Dermatology introduced Mirajet to all its branches nationwide last year and has been applying it in treatments since then.

According to Jinwoo Jeon, Mirajet is a device that creates strong pressure by instantly exploding a laser when it meets water. This transforms liquid medication into a micro-jet form and accurately injects it into the desired skin layer in a uniform amount.

Not only does it deliver medication, but it also creates a suction effect by spreading instantaneously through the skin layer, stimulating fibroblasts, and promoting collagen synthesis. Numerous clinical cases have confirmed its effectiveness not only in improving skin elasticity but also in scar and wrinkle treatments. In particular, the medical staff who attended the seminar on that day evaluated the various possibilities of Mirajet's application.

They stated, 'After introducing Mirajet to all RenewMe Dermatology branches in the second half of last year and focusing on medication injection for scar and wrinkle conditions, we realized through direct interaction with many medical staff that Mirajet can be used in much more diverse fields than expected, not limited to specific medications and conditions.'

Furthermore, the medical staff expressed their belief that if RenewMe Dermatology Network and JSK Biomed cooperate more actively in the future, they can create exceptional clinical research results.

출처 : 헬스경향(http://www.k-health.com)RenewMe Dermatology announced that it successfully completed a seminar held exclusively for its affiliated medical staff on March 17th.

This seminar featured eight programs in the morning and a live seminar in the afternoon. The medical staff at RenewMe Dermatology had the opportunity to exchange their know-how on treating specific skin conditions and their unique golden combinations of various dermatological devices used for skin beauty treatments.

Especially noteworthy from this seminar was the enthusiastic response to Mirajet, a needle-free injection device based on laser technology developed by JSK Biomed. JSK Biomed's CEO, Jinwoo Jeon, who attended the event, communicated with the medical staff, unveiling a newly established treatment protocol based on several years of clinical research. RenewMe Dermatology introduced Mirajet to all its branches nationwide last year and has been applying it in treatments since then.

According to Jinwoo Jeon, Mirajet is a device that creates strong pressure by instantly exploding a laser when it meets water. This transforms liquid medication into a micro-jet form and accurately injects it into the desired skin layer in a uniform amount.

Not only does it deliver medication, but it also creates a suction effect by spreading instantaneously through the skin layer, stimulating fibroblasts, and promoting collagen synthesis. Numerous clinical cases have confirmed its effectiveness not only in improving skin elasticity but also in scar and wrinkle treatments. In particular, the medical staff who attended the seminar on that day evaluated the various possibilities of Mirajet's application.

They stated, 'After introducing Mirajet to all RenewMe Dermatology branches in the second half of last year and focusing on medication injection for scar and wrinkle conditions, we realized through direct interaction with many medical staff that Mirajet can be used in much more diverse fields than expected, not limited to specific medications and conditions.'

Furthermore, the medical staff expressed their belief that if RenewMe Dermatology Network and JSK Biomed cooperate more actively in the future, they can create exceptional clinical research results.

출처 : 헬스경향(http://www.k-health.com)RenewMe Dermatology announced that it successfully completed a seminar held exclusively for its affiliated medical staff on March 17th.

This seminar featured eight programs in the morning and a live seminar in the afternoon. The medical staff at RenewMe Dermatology had the opportunity to exchange their know-how on treating specific skin conditions and their unique golden combinations of various dermatological devices used for skin beauty treatments.

Especially noteworthy from this seminar was the enthusiastic response to Mirajet, a needle-free injection device based on laser technology developed by JSK Biomed. JSK Biomed's CEO, Jinwoo Jeon, who attended the event, communicated with the medical staff, unveiling a newly established treatment protocol based on several years of clinical research. RenewMe Dermatology introduced Mirajet to all its branches nationwide last year and has been applying it in treatments since then.

According to Jinwoo Jeon, Mirajet is a device that creates strong pressure by instantly exploding a laser when it meets water. This transforms liquid medication into a micro-jet form and accurately injects it into the desired skin layer in a uniform amount.

Not only does it deliver medication, but it also creates a suction effect by spreading instantaneously through the skin layer, stimulating fibroblasts, and promoting collagen synthesis. Numerous clinical cases have confirmed its effectiveness not only in improving skin elasticity but also in scar and wrinkle treatments. In particular, the medical staff who attended the seminar on that day evaluated the various possibilities of Mirajet's application.

They stated, 'After introducing Mirajet to all RenewMe Dermatology branches in the second half of last year and focusing on medication injection for scar and wrinkle conditions, we realized through direct interaction with many medical staff that Mirajet can be used in much more diverse fields than expected, not limited to specific medications and conditions.'

Furthermore, the medical staff expressed their belief that if RenewMe Dermatology Network and JSK Biomed cooperate more actively in the future, they can create exceptional clinical research results.

출처 : 헬스경향(http://www.k-health.com)RenewMe Dermatology announced that it successfully completed a seminar held exclusively for its affiliated medical staff on March 17th.

This seminar featured eight programs in the morning and a live seminar in the afternoon. The medical staff at RenewMe Dermatology had the opportunity to exchange their know-how on treating specific skin conditions and their unique golden combinations of various dermatological devices used for skin beauty treatments.

Especially noteworthy from this seminar was the enthusiastic response to Mirajet, a needle-free injection device based on laser technology developed by JSK Biomed. JSK Biomed's CEO, Jinwoo Jeon, who attended the event, communicated with the medical staff, unveiling a newly established treatment protocol based on several years of clinical research. RenewMe Dermatology introduced Mirajet to all its branches nationwide last year and has been applying it in treatments since then.

According to Jinwoo Jeon, Mirajet is a device that creates strong pressure by instantly exploding a laser when it meets water. This transforms liquid medication into a micro-jet form and accurately injects it into the desired skin layer in a uniform amount.

Not only does it deliver medication, but it also creates a suction effect by spreading instantaneously through the skin layer, stimulating fibroblasts, and promoting collagen synthesis. Numerous clinical cases have confirmed its effectiveness not only in improving skin elasticity but also in scar and wrinkle treatments. In particular, the medical staff who attended the seminar on that day evaluated the various possibilities of Mirajet's application.

They stated, 'After introducing Mirajet to all RenewMe Dermatology branches in the second half of last year and focusing on medication injection for scar and wrinkle conditions, we realized through direct interaction with many medical staff that Mirajet can be used in much more diverse fields than expected, not limited to specific medications and conditions.'

Furthermore, the medical staff expressed their belief that if RenewMe Dermatology Network and JSK Biomed cooperate more actively in the future, they can create exceptional clinical research results.